Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs Amlodipine in Non-Diabetic Proteinuric Nephropathy
NCT00140985Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2000
- Primary completion
- Jan 2002
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of losartan in Chronic Nondiabetic Proteinuric Nephropathy and hypertension (HTN) (2 arms), sponsored by Organon & Co. Primary endpoint: 24h proteinuria. Started Feb 2000; status: completed.
02
Drugs
losartan
03
Conditions
Chronic Nondiabetic Proteinuric Nephropathyhypertension (HTN)
Beyond the preview
Go deeper on NCT00140985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140985.